Option chain shows key data for XTL Biopharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for XTL Biopharmaceuticals.

XTL Biopharmaceuticals (NASDAQ:XTLB) Stock, Option Chain

XTL Biopharmaceuticals

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

movers

News

Intraday Update

Markets

Movers

Trading Ideas

AGRI

ALLG

AMCX

ATRA

AVTE

BIMI

BJDX

BMEA

BTDR

CETX

CNSP

EVTV

FCEL

FLFV

KAVL

LRHC

LXRX

MBIO

MEDS

MIRM

MYTE

NDRA

OUST

OVID

PRMW

SCNI

SCPX

SPCE

SYNX

TRNR

VERO

WKHS

XPOF

XTLB

XXII

Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

movers image

Pre-Market Outlook

ICCM

NRIX

SVMH

ZAPP

Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

ABBV

AEHR

AKAN

BCAN

BCLI

CIFR

COOT

CYTO

CZOO

EGOX

ESPR

FLGC

FRGE

GDRX

IVVD

JWEL

LABP

LASE

LCID

LDOS

LICN

LICY

LPRO

MASI

MLGO

MSTR

NKTX

OCGN

OKYO

OTRK

SGMT

SINT

SLRX

SOND

STIM

SWVL

URGN

VMEO

Shares of  Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals Ltd

TSLA

New California EV Credit Would Exclude Tesla Under Proposal

WIIM

TECH

Bio-Techne shares are trading higher after Gemini Bioproducts acquired the company's product rights and inventory of selected fetal bovine serum.

<p>Deep-pocketed investors have adopted a bullish approach towards Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in WDAY usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Workday. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 63% leaning bullish and 27% bearish. Among these notable options, 3 are puts, totaling $139,697, and 8 are calls, amounting to $359,531.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $260.0 to $305.0 for Workday over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Workday stands at 409.9, with a total volume reaching 1,857.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Workday, situated within the strike price corridor from $260.0 to $305.0, throughout the last 30 days.</p>
<h3>Workday Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732558526_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$7.3</td>
<td>$6.7</td>
<td>$7.33</td>
<td>$287.50</td>
<td>$71.1K</td>
<td>15</td>
<td>210</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$13.8</td>
<td>$13.7</td>
<td>$13.7</td>
<td>$275.00</td>
<td>$68.5K</td>
<td>84</td>
<td>65</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$6.6</td>
<td>$6.2</td>
<td>$6.55</td>
<td>$290.00</td>
<td>$65.5K</td>
<td>159</td>
<td>1.0K</td>
</tr>
<tr>
<td>WDAY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$8.5</td>
<td>$8.3</td>
<td>$8.4</td>
<td>$260.00</td>
<td>$59.6K</td>
<td>1.9K</td>
<td>192</td>
</tr>
<tr>
<td>WDAY</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$40.8</td>
<td>$39.6</td>
<td>$40.15</td>
<td>$280.00</td>
<td>$40.1K</td>
<td>134</td>
<td>10</td>
</tr>
</tbody>
</table>
</p>
<h3>About Workday</h3>
<p>Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 18,000 employees.</p>
<p>Having examined the options trading patterns of Workday, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Workday Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,595,656, the WDAY's price is up by 0.26%, now at $268.44. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 1 days.</li>
</ul>
<h3>Expert Opinions on Workday</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $303.3333333333333.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Loop Capital persists with their Hold rating on Workday, maintaining a target price of $270.<br />
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $300.<br />
&#x2A; In a cautious move, an analyst from Scotiabank downgraded its rating to Sector Outperform, setting a price target of $340. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Workday, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

WDAY

Check Out What Whales Are Doing With WDAY

<p>Deep-pocketed investors have adopted a bearish approach towards D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DHI usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 28 extraordinary options activities for D.R. Horton. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 32% leaning bullish and 35% bearish. Among these notable options, 18 are puts, totaling $854,878, and 10 are calls, amounting to $678,985.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $145.0 and $200.0 for D.R. Horton, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for D.R. Horton's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of D.R. Horton's whale trades within a strike price range from $145.0 to $200.0 in the last 30 days. </p>
<h3>D.R. Horton Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732558522_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$7.9</td>
<td>$7.8</td>
<td>$7.9</td>
<td>$200.00</td>
<td>$153.1K</td>
<td align="right">86</td>
<td align="right">194</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$6.1</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$190.00</td>
<td>$120.0K</td>
<td align="right">198</td>
<td align="right">478</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$39.7</td>
<td>$38.4</td>
<td>$39.07</td>
<td>$145.00</td>
<td>$97.7K</td>
<td align="right">73</td>
<td align="right">25</td>
</tr>
<tr>
<td>DHI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$17.2</td>
<td>$16.9</td>
<td>$16.9</td>
<td>$185.00</td>
<td>$79.4K</td>
<td align="right">89</td>
<td align="right">248</td>
</tr>
<tr>
<td>DHI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$13.5</td>
<td>$12.6</td>
<td>$12.9</td>
<td>$165.00</td>
<td>$64.5K</td>
<td align="right">116</td>
<td align="right">100</td>
</tr>
</tbody>
</table>
</p>
<h3>About D.R. Horton</h3>
<p>D.R. Horton is a leading homebuilder in the United States with operations in 125 markets across 36 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.</p>
<p>In light of the recent options history for D.R. Horton, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of D.R. Horton</h3>
<ul>
<li>Currently trading with a volume of 1,487,893, the DHI's price is up by 6.28%, now at $173.8. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 57 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for D.R. Horton with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Looking At D.R. Horton's Recent Unusual Options Activity

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Barrick Gold</strong>.</p>
<p>Looking at options history for Barrick Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) we detected 13 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 30% with bearish.</p>
<p>From the overall spotted trades, 9 are puts, for a total amount of $416,469 and 4, calls, for a total amount of $361,745.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $22.0 for Barrick Gold over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Barrick Gold's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Barrick Gold's whale activity within a strike price range from $10.0 to $22.0 in the last 30 days. </p>
<h3>Barrick Gold 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732558517_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GOLD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$6.55</td>
<td>$5.55</td>
<td>$6.13</td>
<td>$13.00</td>
<td>$254.3K</td>
<td>975</td>
<td align="right">0</td>
</tr>
<tr>
<td>GOLD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$4.55</td>
<td>$4.45</td>
<td>$4.5</td>
<td>$22.00</td>
<td>$72.0K</td>
<td>2.7K</td>
<td align="right">160</td>
</tr>
<tr>
<td>GOLD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$21.00</td>
<td>$69.9K</td>
<td>866</td>
<td align="right">184</td>
</tr>
<tr>
<td>GOLD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$4.7</td>
<td>$4.65</td>
<td>$4.7</td>
<td>$22.00</td>
<td>$66.7K</td>
<td>1.9K</td>
<td align="right">142</td>
</tr>
<tr>
<td>GOLD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$3.2</td>
<td>$3.05</td>
<td>$3.08</td>
<td>$20.00</td>
<td>$44.4K</td>
<td>15.4K</td>
<td align="right">143</td>
</tr>
</tbody>
</table>
</p>
<h3>About Barrick Gold</h3>
<p>Based in Toronto, Barrick Gold is one of the world's largest gold miners. In 2023, the firm produced nearly 4.1 million attributable ounces of gold and about 420 million pounds of copper. At year-end 2023, Barrick had about two decades of gold reserves along with significant copper reserves. After buying Randgold in 2019 and combining its Nevada mines in a joint venture with competitor Newmont later that year, it operates mines in 19 countries in the Americas, Africa, the Middle East, and Asia. The company also has growing copper exposure. Its potential Reko Diq project in Pakistan, if developed, could double copper production by the end of the decade.</p>
<p>Having examined the options trading patterns of Barrick Gold, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Barrick Gold Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 12,746,649, the GOLD's price is down by -3.56%, now at $17.57. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 79 days.</li>
</ul>
<h3>What Analysts Are Saying About Barrick Gold</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $23.666666666666668.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Raymond James continues to hold a Outperform rating for Barrick Gold, targeting a price of $25.<br />
&#x2A; An analyst from Scotiabank persists with their Sector Outperform rating on Barrick Gold, maintaining a target price of $24.<br />
&#x2A; Reflecting concerns, an analyst from UBS lowers its rating to Neutral with a new price target of $22.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Barrick Gold options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


GOLD

Barrick Gold Unusual Options Activity For November 25

<p>With a changing of the guard at 1600 Pennsylvania Avenue, many are wondering how Trump will affect the stock market.</p>
<p>Time will tell, but seeds are already being planted in Washington, D.C., that will reveal which sectors and stocks will prosper under a Trump administration.</p>
<p>"Knowing that President-elect Trump likes to use the market as a scorecard for his success, one would expect that the administration will take a measured approach in policy rollout," says Mark Malek, CIO at Siebert, a financial services firm in&nbsp; New York, N.Y. "Increasing the deficit is not bad if the returns on that investment are acceptable. Growth, through careful, well thought out strategy, can indeed be really positive."</p>
<p>Other market specialists say Wall Street is anticipating a market renaissance starting in 2025 – hopefully.</p>
<p>To cash in on the positives and get out ahead of negatives, it&#8217;s important to act as soon as possible.</p>
<p><strong>Here are the stocks and sectors to buy, and to sell, before Trump&#8217;s second Inauguration Day.</strong></p>
<p>"The stock market has been red hot since Donald Trump's election," says Kevin Connor, founder and CEO of Modern SBC, a strategic business brand firm in Philadelphia, PA. "It's like a giant game of Jenga: everyone is adjusting their moves, anticipating what might collapse and what will collapse under the weight of his policies. For anyone who breathes economic trends, it's fascinating to watch."</p>
<p>Connor believes the market has already shown its cards and is betting big on Trump.</p>
<p>"The Dow rose, reflecting strong optimism about his promises to cut taxes, reduce regulations, and pour a mountain of money into infrastructure," he says. "But the problem is that campaign promises don&#8217;t always match reality. While there&#8217;s a lot of excitement, there&#8217;s also that cloud of &#8220;what if?&#8221; scenarios already in play."</p>
<h2 class="wp-block-heading">Stocks to Buy</h2>
<h3 class="wp-block-heading">Energy</h3>
<p>Following his campaign script, Trump is betting everything on traditional energy sources like oil, gas, and coal. "Big energy companies are thrilled with the idea of ​​reduced regulations and expanded drilling rights," Connor says.</p>
<p>That could lead to big gains for sector companies like Enterprise Products Partners (<a href="https://research.investors.com/quote.aspx?symbol=EPD">EPD</a>) and Riley Exploration Permian (<a href="https://research.investors.com/quote.aspx?symbol=REPX">REPX</a>). EPD&#8217;s shares have risen 5% in the past five days, while REPX&#8217;s shares rose 3.9% in the same time period.FinanceA Trump administration appears favorable for the financial sector. "Trump has suggested he&#8217;s not a fan of Dodd-Frank, the legislation that tightened the rules for banks after the financial crisis," Connor notes. "If regulations are eased, big banks could see their profits rise significantly."</p>
<p>That could be a boon to big bank stocks like JPMorgan Chase (JPM) and Bank of America (BAC). Both companies&#8217; shares have risen 9% over the past 30 days. DefenseWith guarantees of larger defense budgets, defense contractors are looking at a boom time.</p>
<p>"Companies like Lockheed Martin (LMT) ought to see their contracts grow," says Jason Hishmeh, a tech sector investor and CTO at Varyance and Get Startup Funding in New York, N.Y.&nbsp;</p>
<p>Connor agrees with that sentiment, noting LMT should be in line "for a lot of new contracts."</p>
<p>Cyber security companies should prosper as the GOP calls the shots in D.C. "This will be a large step forward in the virtual protection realm," Hishmeh says.<br /><br />Stocks To Sell On the downside, some industries may face an uphill climb in a Trump regime. These sectors lead that list.</p>
<h3 class="wp-block-heading">The Automobile Industry</h3>
<p>Malek says Trump's proposed 60% tariff on Chinese goods, along with Biden's existing 100% tariff on Chinese-made electric vehicles, would significantly impact the automobile industry, particularly electric vehicles (EVs) and their supply chains.</p>
<p>"European manufacturers like BMW, Volkswagen, and Mercedes-Benz could also face renewed tariffs, adding strain to the sector as well as driving up the core goods CPI<em>," </em>he says.Consumer ElectronicsMalek notes that a universal 10% tariff on imports, combined with existing Chinese tariffs, would increase costs for companies like Apple (AAPL), Microsoft (MSFT), and Tesla (TSLA), which uses Chinese-manufactured parts.</p>
<p>"The consumer electronics industry, heavily reliant on imported components, would see production costs rise, potentially reducing profit margins," he says. "The reduced margins would be passed along to consumers causing core goods inflation."Technology CompaniesExpect the technology sector to feel the heat on some of Trump's policies, and one in particular.</p>
<p>"If Trump&#8217;s immigration regulations tighten or exchange becomes more complicated, companies that rely upon those elements ought to struggle," Hishmeh says. "For example, startups that rely upon H-1B visas or worldwide delivery chains can also additionally want to reconsider their strategies."The Big PictureMuch depends on what President-elect Trump says and does while in office.</p>
<p>"Markets, as we all know, can be temperamental, changing moods quickly," Malek says. "Just like with investing reactively, it can cause pain. If Trump is too reactive to daily market moves as he was during some passages of his first term, he and many others may get whipsawed."</p>
<p>The economy still has several key burdens to bear, but Malek sees the economic clouds largely lifting.</p>
<p>"Markets this time around are more fully valued than they were in the past, and inflation is a healing but still sore wound, and monetary policy is significantly tighter," he says. "The good news is that companies are in healthier shape for the most part, which may help keep equities on their secular positive trajectory, but it certainly will come with higher short-run volatility."Hopefully, Trump's sensitivity to the equity markets should result in a more measured approach to tariff policy.</p>
<p>"The bond market, with its powerful vigilantes, has sent a clear warning message," Malek adds. "Trump only needs to look back to the Reagan era to see that those vigilantes can cause some upset."</p>
<p>"Hopes are high, but unfortunately, hope is not a good investment strategy," he adds.</p>
<p>This year, Nic Chahine's alerts delivered gains like 72% on VIX in 12 days, 50% on NVDA in 24 hours, and 33% on TLT in 20 days. Now, similar setups are forming. During Black Friday, access real-time alerts and trade guidance from Wall Street veterans for a fraction of the cost. <strong><a href="https://www.benzinga.com/premium/ideas/options-inner-circle-chat-room-checkout-black-friday/?utm_source=WebRD-1125">Click here to access our limited-time offer now.</a></strong></p>
<p>Lockheed Martin via its Flickr page</p>


Opinion

Stocks to Buy (and Sell) Before Inauguration Day

<p>A mix of easing global geopolitical tensions, post-election bullish momentum and favorable seasonal trends propelled major U.S. stock indices to new record heights during Monday morning trading, marking what could be another <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/markets&amp;ved=2ahUKEwjAlZHc__eJAxU2BfsDHQLbGvkQFnoECCsQAQ&amp;usg=AOvVaw1FmExYgZnKyK1W0mkY7TrX">historic session on Wall Street.</a></p>
<p>The<strong> S&amp;P 500</strong> and <strong>Dow Jones Industrial Average</strong> surged to all-time records, hitting intraday highs of 6,020 and 44,815 points, respectively, before paring back some gains.</p>
<p>Yet, the small-cap <strong>Russell 2000 </strong>index stole the spotlight, up 1.4% and reaching an all-time high for the first time since November 2021.</p>
<p>Investors cheered President-elect <strong>Donald Trump</strong>'s nomination of hedge fund manager<strong> Scott Bessent</strong> for Treasury Secretary, betting his Wall Street experience could steer fiscal policies<a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/news/24/11/42158330/trumps-treasury-secretary-pick-scott-bessent-says-a-global-economic-reordering-is-on-the-way-argues-president-elects-policies-will-lead-to-an-economic-lollapalooza&amp;ved=2ahUKEwjl2srK__eJAxV3KvsDHal-N2sQFnoECCAQAQ&amp;usg=AOvVaw2RHZDfMG584ba6QTHSP-jq"> toward a pro-market direction</a>. </p>
<p>Meanwhile, the barometer of geopolitical fears eased as Israel and Lebanon agreed to a framework for <a href="https://www.benzinga.com/24/11/42166676/israel-reaches-groundbreaking-ceasefire-deal-with-lebanon-gold-oil-tumble-sp-500-dow-jointly-hit-record-highs">ending the Israel-Hezbollah conflict</a>. While the deal still requires approval from Israel&#8217;s Security Cabinet, traders embraced the news, which sent ripples through commodity markets.</p>
<p>West Texas Intermediate (WTI) crude tumbled 2.7%, falling below $70 per barrel, erasing Friday&#8217;s gains. Gold plummeted over 3%, marking one of its worst sessions in 2024, as safe-haven demand receded.</p>
<p>Bucking the trend, natural gas prices soared 8%, driven by reports that Trump's team is preparing to end Biden's freeze on liquefied natural gas (LNG) exports.</p>
<p>U.S. Treasury yields plunged as optimism around Bessent's nomination suggested a potential curb on unchecked deficit spending. The yield on the 10-year Treasury note fell more than 10 basis points to 4.29%, dragging the U.S. dollar down 0.6%.</p>
<p>While traditional equities rallied, the risk-on sentiment did not extend to cryptocurrencies. <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dropped 3% to around $95,000, further distancing itself from the highly anticipated $100,000 milestone.</p>
<h1 class="wp-block-heading"><strong>Monday&#8217;s Performance In U.S. Major Indices, ETFs</strong></h1>
<p><figure class="wp-block-table is-style-stripes"><br />
<table>
<tbody>
<tr>
<td><strong>Major Indices</strong></td>
<td><strong>Price</strong></td>
<td><strong>1-day % chg</strong>.</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,439.45</td>
<td>1.4%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,565.41</td>
<td>0.6%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,974.05</td>
<td>0.1%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,745.11</td>
<td>-0.1%</td>
</tr>
</tbody>
</table>
<p><figcaption class="wp-element-caption"><em>Updated at 12:35 p.m. ET</em></figcaption></p></figure></p>
<p><strong>According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent112524&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:</strong></p>
<ul>
<li>The&nbsp;<strong>SPDR S&amp;P 500 ETF Trust</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) edged 0.1% higher to $596.04, eyeing the sixth straight session of gains.</li>
<li>The&nbsp;<strong>SPDR Dow Jones Industrial Average&nbsp;</strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;rose 0.6% to $445.93.</li>
<li>The tech-heavy&nbsp;<strong>Invesco QQQ Trust Series</strong>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) inched 0.065% up to $506.12.</li>
<li>The&nbsp;<strong>iShares Russell 2000 ETF</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rallied 1.5% to $242.71.</li>
<li>The&nbsp;<strong>Consumer Discretionary Sector Select Sector SPDR Fund</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, rising 1.2%. The&nbsp;<strong>Energy Select Sector SPDR Fund</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.6%.</li>
</ul>
<h1 class="wp-block-heading"><strong>Monday&#8217;s Stock Movers</strong></h1>
<ul>
<li><strong>Bath &amp; Body Works Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) rallied 14.5% in reaction to better-than-expected quarterly earnings. </li>
<li><strong>Macy&#8217;s Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) fell over 3% after the company announced that a former employee allegedly concealed between $132 million and $154 million in delivery expenses from the fiscal fourth quarter of 2021 through the most recent <a href="https://www.benzinga.com/24/11/42166888/stock-of-the-day-accounting-fraud-at-macys">quarter ending Nov. 2</a>. As a result, it has postponed its earnings release and conference call to as late as Dec. 11 to allow time for an independent audit.</li>
<li><strong>Rivian Automotive Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) soared 13%, after Volkswagen announced to boost its initial investment by an additional $800 million to $5.8 billion.</li>
</ul>
<p><strong>Read Now:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42170135/its-the-most-wonderful-time-of-the-year-for-the-stock-market-history-says">&#8216;It&#8217;s The Most Wonderful Time Of The Year&#8217; For The Stock Market, History Says</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Government

Large Cap

Mid Cap

Broad U.S. Equity ETFs

Commodities

Tech

ETFs

$BTC

BBWI

SPDR Dow Jones Industrial Average ETF Trust

RIVN

Select Sector SPDR-Consumer Discretionary

Russell 2000, Dow, S&P 500 All Achieve Record Highs In Wall Street's Historic Day; Bitcoin, Gold Tumble: What's Driving Markets Monday?

<p>Consolidating Operations With Automated Systems, Enhanced Sustainability, And Compliance With Food Safety Standards To Serve Asian Markets</p>


TriMas Packaging Opens 225,000 Sq. Ft. Advanced Facility In Haining, China

Analyst Ratings

COWZ

MELI

CNBC Halftime Report Final Trades: Domino's Pizza, Vertiv, MercadoLibre, Pacer US Cash Cows 100 ETF

<p>Euronet Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEFT#NASDAQ">EEFT</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Euronet Worldwide, revealing an average target of $124.5, a high estimate of $136.00, and a low estimate of $110.00. A 0.4% drop is evident in the current average compared to the previous average price target of $125.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557698_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of Euronet Worldwide among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rayna Kumar</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$135.00</td>
<td>$121.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Andrew Schmidt</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Peter Heckmann</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$136.00</td>
<td>$136.00</td>
</tr>
<tr>
<td>Rayna Kumar</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$121.00</td>
<td>-</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Euronet Worldwide. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Euronet Worldwide compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Euronet Worldwide's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Euronet Worldwide's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EEFT/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Euronet Worldwide analyst ratings.</strong></a></p>
<h2>Discovering Euronet Worldwide: A Closer Look</h2>
<p>Euronet Worldwide Inc is a provider of electronic financial transaction solutions. The company operates an independent network of ATMs in Europe, along with a network for prepaid products such as mobile top-ups, and processes point-of-sale transactions. It operates in three segment EFT Processing Segment, epay Segment, and Money Transfer Segment. Its segment revenue comes from by operating income, electronical financial transaction processing, mainly generates revenue from monthly ATM management fees and currency conversion transactions. It generates the majority if its geographic revenue from the United States of America.</p>
<h3>Breaking Down Euronet Worldwide's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Euronet Worldwide's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>9.49%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> Euronet Worldwide's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>13.78%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Euronet Worldwide's ROE excels beyond industry benchmarks, reaching <strong>11.77%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Euronet Worldwide's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>2.45%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>1.78</strong>, caution is advised due to increased financial risk.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


EEFT

Analyst Ratings For Euronet Worldwide

<p>Ratings for Essential Props Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPRT#NYSE">EPRT</a>) were provided by 11 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $35.39, along with a high estimate of $40.00 and a low estimate of $32.00. This current average reflects an increase of 5.48% from the previous average price target of $33.55. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557690_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The standing of Essential Props Realty among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg McGinniss</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$33.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Vikram Malhorta</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Connor Siversky</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$39.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Greg McGinniss</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$32.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Ki Bin Kim</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$36.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Connor Siversky</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Simon Yarmak</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$36.25</td>
<td>$32.00</td>
</tr>
<tr>
<td>Sheila McGrath</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$34.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Sheila McGrath</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$33.00</td>
<td>$32.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Essential Props Realty. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Essential Props Realty compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Essential Props Realty's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Essential Props Realty's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EPRT/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Essential Props Realty analyst ratings.</strong></a></p>
<h2>All You Need to Know About Essential Props Realty</h2>
<p>Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses.</p>
<h3>Essential Props Realty: Financial Performance Dissected</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Essential Props Realty's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>27.79%</strong>. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> Essential Props Realty's net margin is impressive, surpassing industry averages. With a net margin of <strong>41.85%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Essential Props Realty's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.52%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>0.91%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.69</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


EPRT

Peeling Back The Layers: Exploring Essential Props Realty Through Analyst Insights

<p>21 analysts have shared their evaluations of Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">13</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">11</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $85.0, with a high estimate of $93.00 and a low estimate of $79.00. This upward trend is apparent, with the current average reflecting a 5.88% increase from the previous average price target of $80.28.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557667_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The standing of Nasdaq among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Brian Bedell</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$80.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Kevin Heal</td>
<td>Argus Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$82.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$80.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$87.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$86.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$93.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$92.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Patrick O'Shaughnessy</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Outperform</td>
<td>$82.00</td>
<td>-</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$84.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Alex Kramm</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$79.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Richard Repetto</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$84.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$88.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Alexander Blostein</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$83.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$88.00</td>
<td>-</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Hold</td>
<td>$83.00</td>
<td>-</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$90.00</td>
<td>$53.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Nasdaq. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Nasdaq compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Nasdaq's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Nasdaq's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NDAQ/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Nasdaq analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Nasdaq</h2>
<p>Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.</p>
<h3>Nasdaq's Financial Performance</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Nasdaq showcased positive performance, achieving a revenue growth rate of <strong>31.08%</strong> as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Nasdaq's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>16.09%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Nasdaq's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.79%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Nasdaq's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>1.01%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> Nasdaq's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>0.93</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


NDAQ

Analyst Ratings For Nasdaq

<p>4 analysts have shared their evaluations of Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Helen Of Troy, revealing an average target of $81.25, a high estimate of $92.00, and a low estimate of $71.00. Surpassing the previous average price target of $76.50, the current average has increased by 6.21%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557654_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Helen Of Troy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$71.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$92.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$84.00</td>
<td>$84.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Helen Of Troy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Helen Of Troy compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Helen Of Troy's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Capture valuable insights into Helen Of Troy's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HELE/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Helen Of Troy analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know Helen Of Troy Better</h2>
<p>Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home &amp; Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty &amp; Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.</p>
<h3>Helen Of Troy: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Helen Of Troy faced challenges, resulting in a decline of approximately <strong>-3.53%</strong> in revenue growth as of 31 August, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Helen Of Troy's net margin excels beyond industry benchmarks, reaching <strong>3.59%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Helen Of Troy's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>1.09%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Helen Of Troy's ROA excels beyond industry benchmarks, reaching <strong>0.6%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.48</strong>.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


HELE

The Latest Analyst Ratings For Helen Of Troy

<p>Financial giants have made a conspicuous bearish move on AbbVie. Our analysis of options history for AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) revealed 13 unusual trades.</p>
<p>Delving into the details, we found 38% of traders were bullish, while 53% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $257,880, and 10 were calls, valued at $538,961.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $160.0 to $192.5 for AbbVie during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for AbbVie's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across AbbVie's significant trades, within a strike price range of $160.0 to $192.5, over the past month.</p>
<h3>AbbVie Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557634_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$6.55</td>
<td>$6.3</td>
<td>$6.3</td>
<td>$175.00</td>
<td>$189.0K</td>
<td>689</td>
<td align="right">319</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$14.95</td>
<td>$14.2</td>
<td>$14.2</td>
<td>$165.00</td>
<td>$142.0K</td>
<td>4.0K</td>
<td align="right">107</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$26.75</td>
<td>$26.4</td>
<td>$26.4</td>
<td>$165.00</td>
<td>$124.0K</td>
<td>490</td>
<td align="right">47</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.92</td>
<td>$1.78</td>
<td>$1.8</td>
<td>$185.00</td>
<td>$54.0K</td>
<td>3.6K</td>
<td align="right">695</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$180.00</td>
<td>$36.6K</td>
<td>4.7K</td>
<td align="right">328</td>
</tr>
</tbody>
</table>
</p>
<h3>About AbbVie</h3>
<p>AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).</p>
<h3>AbbVie's Current Market Status</h3>
<ul>
<li>With a trading volume of 3,563,685, the price of ABBV is up by 0.2%, reaching $177.31.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 67 days from now.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Market Whales and Their Recent Bets on ABBV Options

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>AST SpaceMobile</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ASTS, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 15 options trades for <strong>AST SpaceMobile</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 40%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $66,690, and 14, calls, for a total amount of $914,577.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $12.5 to $35.0 for AST SpaceMobile over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for AST SpaceMobile's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across AST SpaceMobile's significant trades, within a strike price range of $12.5 to $35.0, over the past month.</p>
<h3>AST SpaceMobile Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557628_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$16.9</td>
<td>$16.5</td>
<td>$16.5</td>
<td>$12.50</td>
<td>$160.0K</td>
<td>16.9K</td>
<td align="right">261</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$15.3</td>
<td>$15.3</td>
<td>$15.3</td>
<td>$12.50</td>
<td>$116.2K</td>
<td>16.9K</td>
<td align="right">158</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.5</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$12.50</td>
<td>$115.5K</td>
<td>16.9K</td>
<td align="right">79</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$4.1</td>
<td>$4.0</td>
<td>$4.0</td>
<td>$22.00</td>
<td>$98.8K</td>
<td>4</td>
<td align="right">247</td>
</tr>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.9</td>
<td>$2.85</td>
<td>$2.85</td>
<td>$25.00</td>
<td>$66.6K</td>
<td>2.5K</td>
<td align="right">243</td>
</tr>
</tbody>
</table>
</p>
<h3>About AST SpaceMobile</h3>
<p>AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers and finally bringing broadband to the billions who remain unconnected. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.</p>
<p>Having examined the options trading patterns of AST SpaceMobile, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is AST SpaceMobile Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 6,772,881, the ASTS's price is up by 2.03%, now at $24.59. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 126 days.</li>
</ul>
<h3>Expert Opinions on AST SpaceMobile</h3>
<p>A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $37.85.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Scotiabank keeps a Sector Outperform rating on AST SpaceMobile with a target price of $44.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for AST SpaceMobile, targeting a price of $31. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AST SpaceMobile options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


ASTS

AST SpaceMobile Unusual Options Activity

<p>20 analysts have shared their evaluations of Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">7</td>
<td align="right">6</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Tractor Supply and provided 12-month price targets. The average target is $300.45, accompanied by a high estimate of $335.00 and a low estimate of $250.00. Witnessing a positive shift, the current average has risen by 4.94% from the previous average price target of $286.32.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557629_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Tractor Supply. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$320.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>John Lawrence</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$310.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$280.00</td>
<td>$272.00</td>
</tr>
<tr>
<td>Matthew McClintock</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$290.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Seth Sigman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$250.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Michael Baker</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$325.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>David Bellinger</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$270.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$270.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$317.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$335.00</td>
<td>$335.00</td>
</tr>
<tr>
<td>John Lawrence</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$280.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$335.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Christopher Horvers</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$290.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$325.00</td>
<td>$293.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$332.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$325.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Oliver Wintermantel</td>
<td>Evercore ISI Group</td>
<td>Maintains</td>
<td>In-Line</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>John Lawrence</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$280.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Karen Short</td>
<td>Melius Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$315.00</td>
<td>-</td>
</tr>
<tr>
<td>Anthony Chukumba</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Hold</td>
<td>$260.00</td>
<td>$250.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Tractor Supply. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Tractor Supply compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Tractor Supply's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/TSCO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Tractor Supply analyst ratings.</strong></a></p>
<h2>About Tractor Supply</h2>
<p>Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,270 of its namesake banners in 49 states, including 81 Orscheln Farm and Home stores (rebranded as Tractor Supply), along with 205 Petsense by Tractor Supply stores. Stores are generally concentrated in rural communities, as opposed to urban and suburban areas. In fiscal 2023, revenue consisted primarily of livestock, equine &amp; agriculture (27%), companion animal (25%), and seasonal &amp; recreation (22%).</p>
<h3>Tractor Supply: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Tractor Supply's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>1.65%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Tractor Supply's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>6.96%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>10.51%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.47%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Tractor Supply's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>2.33</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


TSCO

20 Analysts Assess Tractor Supply: What You Need To Know

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Bank of America</strong>.</p>
<p>Looking at options history for Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) we detected 34 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 61% with bearish.</p>
<p>From the overall spotted trades, 11 are puts, for a total amount of $991,182 and 23, calls, for a total amount of $1,983,979.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $39.0 and $55.0 for Bank of America, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Bank of America's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Bank of America's substantial trades, within a strike price spectrum from $39.0 to $55.0 over the preceding 30 days.</p>
<h3>Bank of America 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557622_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.89</td>
<td>$1.85</td>
<td>$1.89</td>
<td>$40.00</td>
<td>$472.7K</td>
<td>27.2K</td>
<td>497</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.25</td>
<td>$1.22</td>
<td>$1.24</td>
<td>$47.00</td>
<td>$368.0K</td>
<td>30.8K</td>
<td>5.2K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.24</td>
<td>$1.21</td>
<td>$1.23</td>
<td>$47.00</td>
<td>$256.7K</td>
<td>30.8K</td>
<td>11.7K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.23</td>
<td>$1.22</td>
<td>$1.22</td>
<td>$47.00</td>
<td>$155.4K</td>
<td>30.8K</td>
<td>4.7K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$0.58</td>
<td>$0.56</td>
<td>$0.58</td>
<td>$48.50</td>
<td>$120.2K</td>
<td>1.9K</td>
<td>10.6K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Bank of America</h3>
<p>Bank of America is one of the largest financial institutions in the United States, with more than $3.0 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.</p>
<p>Following our analysis of the options activities associated with Bank of America, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Bank of America Standing Right Now?</h3>
<ul>
<li>With a volume of 13,458,434, the price of BAC is up 0.87% at $47.41. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 52 days.</li>
</ul>
<h3>What Analysts Are Saying About Bank of America</h3>
<p>Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $55.333333333333336.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Bank of America, maintaining a target price of $56.<br />
&#x2A; An analyst from Oppenheimer persists with their Outperform rating on Bank of America, maintaining a target price of $56.<br />
&#x2A; Showing optimism, an analyst from Citigroup upgrades its rating to Buy with a revised price target of $54. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Bank of America, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Bank of America Options Trading: A Deep Dive into Market Sentiment

<p>During the last three months, 6 analysts shared their evaluations of Golden Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEN#NASDAQ">GDEN</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $37.33, a high estimate of $40.00, and a low estimate of $35.00. A decline of 3.86% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732557619_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>A clear picture of Golden Entertainment's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$36.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Chad Beynon</td>
<td>Macquarie</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$38.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Barry Jonas</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$36.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Chad Beynon</td>
<td>Macquarie</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$39.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>David Bain</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$40.00</td>
<td>$44.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Golden Entertainment. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Golden Entertainment compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Golden Entertainment's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Golden Entertainment's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/GDEN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Golden Entertainment analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Discovering Golden Entertainment: A Closer Look</h2>
<p>Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.</p>
<h3>Financial Milestones: Golden Entertainment's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Challenges:</strong> Golden Entertainment's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately <strong>-37.44%</strong>. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>3.2%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>0.98%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>0.45%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.95</strong>, Golden Entertainment adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


GDEN

What Analysts Are Saying About Golden Entertainment Stock

<p><strong>BofA Securities </strong>downgraded <strong>Editas Medicine Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>), citing few value-driving catalysts <a target="_blank" href="https://www.benzinga.com/quote/EDIT/analyst-ratings" rel="noreferrer noopener">in the near term</a>.</p>
<p>In its third-quarter earnings release, Editas Medicine said it engaged an investment bank to lead the process of partnering or out-licensing reni-cel (renizgamglogene autogedtemcel, previously EDIT-301).</p>
<p>The company is developing reni-cel for sickle cell disease and transfusion-<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41710488/editas-medicine-announces-third-quarter-2024-results-and-business-updates" rel="noreferrer noopener">dependent Beta Thalassemia</a>.</p>
<p>The company is on track to share additional clinical and patient-reported outcomes data from 28 patients in the RUBY trial for sickle cell disease at the American Society of Hematology Annual Meeting in December.</p>
<p>The company has completed enrollment of the adult cohort of the EdiTHAL trial for thalassemia and continues patient dosing.</p>
<p>The analyst notes that Editas announced a shift in focus toward in vivo development, specifically working on lipid nanoparticle (LNP) formulations for treating sickle cell disease (SCD) and thalassemia.</p>
<p>While preclinical data shows some progress—29% editing in hematopoietic stem and progenitor cells (HSPCs) and around 20% of red blood cells expressing fetal hemoglobin (HbF)—more evidence is needed to prove functional benefits and advance to clinical trials.</p>
<p>Meanwhile, competitors like <strong>Beam Therapeutics Inc </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) and <strong>CRISPR Therapeutics AG</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) are investing heavily in their in vivo programs for SCD and thalassemia, with better-prepared manufacturing and development for clinical trials.</p>
<p>Given the deprioritization of reni-cel and the increasingly competitive environment for ex vivo therapies, BofA has reduced estimates and probabilities of success in SCD and beta-thal to 10% (from 60% prior).</p>
<p>The analyst downgraded from Buy to Underperform, with a price target of $1, down from $13.</p>
<p>This intensifying competition, limited short-term clinical milestones, and declining interest in gene editing pose challenges for Editas and could pressure its stock in the near term.</p>
<p><strong>Price Action: </strong>EDIT stock is down 0.41% at $2.43 at last check Monday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/media/24/11/42168509/amd-teams-up-with-taiwan-semi-to-take-on-samsung-in-smartphone-market" target="_blank" rel="noreferrer noopener">AMD Teams Up With Taiwan Semi To Take On Samsung In Smartphone Market</a></strong></li>
</ul>
<p><em>Photo by Ground Picture on Shutterstock.</em></p>


Analyst Color

Biotech

Downgrades

Health Care

Price Target

General

BEAM

CRSP

EDIT

Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts

<p>Evercore ISI Group  analyst Peter Levine   maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Outperform and raises the price target from $325 to $400.</p>


CRWD

Evercore ISI Group Maintains Outperform on CrowdStrike Holdings, Raises Price Target to $400

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>It&rsquo;s time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!</p>



<p>Moving stocks this morning are earnings reports, an acquisition deal, a delisting notice and more.</p>



<p>Let&rsquo;s get into that news below!</p>



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li><strong>Tevogen Bio</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/tvgn-stock-quote/"><strong>TVGN</strong></a>) stock is rocketing more than 71% after announcing <a href="https://www.nasdaq.com/press-release/tevogen-bio-announces-up-to-%2450-million-in-financing-to-further-advance-operational">$50 million in additional financing</a>.</li>



<li><strong>AC Immune</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/aciu-stock-quote/"><strong>ACIU</strong></a>) shares are soaring over 48% alongside its <a href="https://www.nasdaq.com/press-release/ac-immune-reports-first-quarter-2024-financial-results-and-provides-a-corporate">Q1 2024 earnings report</a>.</li>



<li><strong>Nauticus Robotics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/"><strong>KITT</strong></a>) stock is surging more than 31% with heavy pre-market trading.</li>



<li><strong>Dynatronics </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/dynt-stock-quote/"><strong>DYNT</strong></a>) shares are gaining over 21% without any clear news this morning.</li>



<li><strong>GameStop </strong>(NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/"><strong>GME</strong></a>) stock is rising more than 19% with the <a href="https://www.marketwatch.com/story/roaring-kitty-is-back-and-gamestop-stock-is-rallying-the-company-still-is-struggling-to-make-money-ca4607c3">return of Roaring Kitty</a>.</li>



<li><strong>XTL Biopharmaceuticals</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/"><strong>XTLB</strong></a>) shares are increasing over 19% despite a lack of news today.</li>



<li><strong>JanOne </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/jan-stock-quote/"><strong>JAN</strong></a>) stock is climbing more than 16% on plans to <a href="https://www.prnewswire.com/news-releases/janone-to-acquire-alt-5-sigma-inc-a-leading-next-generation-blockchain-financial-technology-provider-302142674.html">acquire <strong>Alt 5 Sigma</strong></a>.</li>



<li><strong>Fulcrum Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/fulc-stock-quote/"><strong>FULC</strong></a>) shares are climbing over 16% on <a href="https://www.nasdaq.com/press-release/fulcrum-therapeutics-enters-into-a-collaboration-and-license-agreement-with-sanofi">a collaboration agreement</a> with <strong>Sanofi&nbsp;</strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/sny-stock-quote/"><strong>SNY</strong></a>)</li>



<li><strong>Plutonian Acquisition</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/pltn-stock-quote/"><strong>PLTN</strong></a>) stock is jumping more than 15% this morning.</li>



<li><strong>Dermata Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/drma-stock-quote/"><strong>DRMA</strong></a>) shares are up over 14% on Monday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li><strong>AEye </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/lidr-stock-quote/"><strong>LIDR</strong></a>) stock is diving close to 14% <a href="https://investorplace.com/2024/05/why-is-aeye-lidr-stock-up-38-today/">following a Friday rally</a>.</li>



<li><strong>Safe &amp; Green Development</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/"><strong>SGD</strong></a>) shares are tumbling about 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318311138&amp;type=PDF&amp;symbol=SGD&amp;cdn=507b0bfaecfda3ee7d6769c0869f5747&amp;companyName=Safe+and+Green+Development+Corporation&amp;formType=D&amp;formDescription=Notice+of+Exempt+Offering+of+Securities&amp;dateFiled=2024-05-10">Notice of Exempt Offering of Securities</a> filing to the Securities and Exchange Commission (SEC).</li>



<li><strong>TransCode Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/"><strong>RNAZ</strong></a>) stock is taking a more than 12% beating alongside plans for its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318310991&amp;type=PDF&amp;symbol=RNAZ&amp;cdn=43164c7cc1aa0080fb04a692a6a78bd2&amp;companyName=TransCode+Therapeutics+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-05-10">annual shareholder meeting</a>.</li>



<li><strong>Visionary </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/gv-stock-quote/"><strong>GV</strong></a>) shares are sliding over 11% following a similar rally on the prior trading day.</li>



<li><strong>Notable Labs</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/ntbl-stock-quote/"><strong>NTBL</strong></a>) stock is dropping more than 11% without any apparent news this morning.</li>



<li><strong>Power REIT</strong> (NYSEMKT:<a href="https://investorplace.com/stock-quotes/pw-stock-quote/"><strong>PW</strong></a>) shares are falling over 10% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318310902&amp;type=PDF&amp;symbol=PW&amp;cdn=11f58b2db1a9e1bae7887bdcbd213c86&amp;companyName=Power+REIT+%28MD%29&amp;formType=10-Q&amp;formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&amp;dateFiled=2024-05-10">rallying Friday on earnings</a>.</li>



<li><strong>Cyngn </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/"><strong>CYN</strong></a>) stock is decreasing more than 10% with <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318311286&amp;type=PDF&amp;symbol=CYN&amp;cdn=ed67470a33a490d78ff90c97e3b68660&amp;companyName=Cyngn+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-05-10">shareholder meeting plans</a>.</li>



<li><strong>Vitesse Energy</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/vts-stock-quote/"><strong>VTS</strong></a>) shares are slipping over 10% on Monday.</li>



<li><strong>AYRO </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/ayro-stock-quote/"><strong>AYRO</strong></a>) stock is dipping more than 9% this morning.</li>



<li><strong>Heart Test Laboratories</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/hscs-stock-quote/"><strong>HSCS</strong></a>) shares close out our pre-market stock movers down over 9% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318310504&amp;type=PDF&amp;symbol=HSCS&amp;cdn=520cd089afcc06b6a1b1e5f350c05d40&amp;companyName=Heart+Test+Laboratories+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-05-10">with a delisting notice</a>.</li>
</ol><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-13th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company, h...

XTL Biopharmaceuticals Expands Portfolio Amidst Profitable Quarter

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. is set to acquire 100% of the issued and outst...

XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD.

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. is set to hold its Annual and Extraordinary Ge...

XTL Biopharmaceuticals Announces Upcoming Shareholder Meeting

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>We have all of the biggest pre-market stock movers that traders will want to read about on Monday morning!</p>



<p>Moving stocks this morning an investor update, clinical trial news, a private offering and more.</p>



<p>Let&rsquo;s get into that news below!</p>



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li><strong>Scinai Immunotherapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/scni-stock-quote/"><strong>SCNI</strong></a>) stock is rocketing more than 69% alongside heavy pre-market trading.</li>



<li><strong>Schmid Group</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/shmd-stock-quote/"><strong>SHMD</strong></a></span>) shares are soaring 40% without any clear news this morning.</li>



<li><strong>ENDRA Life Sciences</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/ndra-stock-quote/"><strong>NDRA</strong></a>) stock is surging over 36% alongside an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318395592&amp;type=PDF&amp;symbol=NDRA&amp;cdn=4506ae3b1a739822361489bedc53ef84&amp;companyName=ENDRA+Life+Sciences+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-06-14">investor stake update</a>.</li>



<li><strong>Maxeon Solar Technologies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/"><strong>MAXN</strong></a>) shares are rising more than 21% with strong early morning trading.</li>



<li><strong>Srivaru </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/"><strong>SVMH</strong></a>) stock is increasing over 18% as it continues to <a href="https://investorplace.com/2024/06/why-is-srivaru-svmh-stock-up-122-today/">rally on e-bike news</a>.</li>



<li><strong>Nurix Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrix-stock-quote/"><strong>NRIX</strong></a>) shares are gaining 17% on <a href="https://www.marketwatch.com/story/nurix-therapeutics-shares-rise-on-positive-leukemia-drug-results-66b9d524?mod=investing">positive drug results</a>.</li>



<li><strong>Icecure Medical</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/iccm-stock-quote/"><strong>ICCM</strong></a>) stock is getting a 14% boost with it still rallying on <a href="https://www.nasdaq.com/press-release/positive-data-icecures-kidney-cancer-clinical-study-presented-interventional">kidney cancer study data</a>.</li>



<li><strong>Kineta </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/ka-stock-quote/"><strong>KA</strong></a>) shares are heading more than 13% higher with heavy trading today.</li>



<li><strong>XTL Biopharmaceuticals</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/"><strong>XTLB</strong></a>) stock is jumping over 12% this morning.</li>



<li><strong>Conn&rsquo;s </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/"><strong>CONN</strong></a>) shares are up more than 11% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li><strong>Kaival Brands Innovations</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/"><strong>KAVL</strong></a>) stock is plummeting more than 35% after a massive rally on Friday.</li>



<li><strong>Sonim Technologies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/sonm-stock-quote/"><strong>SONM</strong></a>) shares are diving over 25% this morning.</li>



<li><strong>AMC Networks</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/amcx-stock-quote/"><strong>AMCX</strong></a>) stock is tumbling more than 23% after <a href="https://www.nasdaq.com/press-release/amc-networks-inc-announces-private-offering-125-million-convertible-senior-notes-2024">announcing a private offering</a>.</li>



<li><strong>Bluejay Diagnostics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/"><strong>BJDX</strong></a>) shares are taking an over 17% beating despite a lack of news.</li>



<li><strong>Northann </strong>(NYSEMKT:<a href="https://investorplace.com/stock-quotes/ncl-stock-quote/"><strong>NCL</strong></a>) stock is falling close to 14% without any news to report.</li>



<li><strong>Zapp Electric Vehicles</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/"><strong>ZAPP</strong></a>) shares are dropping more than 13% as it <a href="https://investorplace.com/2024/06/why-is-zapp-electric-vehicles-zapp-stock-up-173-today/">comes off a rally last week</a>.</li>



<li><strong>Aptevo Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/"><strong>APVO</strong></a>) stock is decreasing over 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396271&amp;type=PDF&amp;symbol=APVO&amp;cdn=21e6c068c48621c307f0f74bc8553007&amp;companyName=Aptevo+Therapeutics+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-06-14">proposed public offering</a>.</li>



<li><strong>Feutune Light Acquisition</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/flfv-stock-quote/"><strong>FLFV</strong></a>) shares are slipping almost 12% on Monday.</li>



<li><strong>Volcon </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/"><strong>VLCN</strong></a>) stock is dipping more than 11% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396398&amp;type=PDF&amp;symbol=VLCN&amp;cdn=980b1d9c3f018f25ac11de4d0e102b66&amp;companyName=Volcon+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-14">a delisting notice</a>.</li>



<li><strong>Holdco Nuvo</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuvo-stock-quote/"><strong>NUVO</strong></a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. successfully held its Annual and Extraordinary...

XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. has successfully acquired The Social Proxy Ltd...

XTL Biopharmaceuticals Expands with AI Company Acquisition

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd., a company known for its intellectual property...

XTL Biopharmaceuticals Faces Financial Dispute After Acquisition

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. has reached a settlement agreement with The So...

XTL Biopharmaceuticals Resolves Dispute with Social Proxy

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. has entered into a settlement agreement involv...

Comments

XTL Biopharmaceuticals

XTL Biopharmaceuticals (XTLB) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga